The 11 most recent market catalysts affecting $LGN, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Aug 19, 2026
Corporate Catalyst
Bullish
Impact 55
Tigress Financial Maintains Buy on Legence, Raises Price Target to $130
Tigress Financial analyst Ivan Feinseth has maintained a 'Buy' rating on Legence (LGN) and raised the price target from $125 to $130. This indicates a continued bullish outlook fro…
Aug 18, 2026
Corporate Catalyst
Neutral
Impact 55
Guggenheim Reiterates Buy on Legence, Maintains $115 Price Target
Guggenheim analyst Joseph Osha has reaffirmed a 'Buy' rating for Legence and kept the price target at $115. This action signals that the analyst's outlook on the company's fundamen…
Aug 14, 2026
Corporate Catalyst
Bullish
Impact 55
B of A Securities Maintains Buy on Legence, Raises Price Target to $116
BofA Securities analyst Sherif El-Sabbahy has maintained a 'Buy' rating on Legence (LGN) and raised the price target from $105 to $116. This action signals continued confidence fro…
Aug 14, 2026
Corporate Catalyst
Bearish
Impact 85
These Analysts Revise Their Forecasts On Legence Following Q2 Results
Legence (LGN) announced mixed second-quarter financial results, missing EPS estimates but exceeding sales forecasts. The company also provided strong third-quarter sales guidance, …
Aug 14, 2026
Corporate Catalyst
Bullish
Impact 55
BMO Capital Maintains Outperform on Legence, Raises Price Target to $105
BMO Capital analyst Devin Dodge maintained an 'Outperform' rating on Legence and raised the price target from $100 to $105. This action signals a positive outlook from a reputable …
Aug 14, 2026
Corporate Catalyst
Bearish
Impact 65
BTIG Reiterates Buy on Legence, Lowers Price Target to $100
This filing indicates that BTIG analyst Gregory Lewis has reaffirmed a 'Buy' rating for Legence (LGN), suggesting continued confidence in the company's fundamentals. However, the a…
Aug 13, 2026
Corporate Catalyst
Bearish
Impact 92
Legence Q2 EPS $0.17 Misses $0.33 Estimate, Sales $1.260B Beat $1.074B Estimate
Legence's Q2 earnings report presents a mixed picture for investors. The substantial miss on EPS (48.48% below estimates) is a significant negative signal, indicating that the comp…
Aug 13, 2026
Corporate Catalyst
Bullish
Impact 85
Legence Raises FY2026 Sales Guidance from $4.100B-$4.300B to $4.700B-$4.800B vs $4.274B Est
Legence (LGN) has announced a substantial upward revision to its FY2026 sales guidance, moving from a range of $4.100B-$4.300B to $4.700B-$4.800B. This new forecast significantly s…
Aug 12, 2026
Corporate Catalyst
Neutral
Impact 55
Roth Capital Reiterates Buy on Legence, Maintains $120 Price Target
Roth Capital analyst Craig Irwin has reaffirmed a 'Buy' rating and a $120 price target for Legence (LGN). This action signals that the analyst's outlook on the company's performanc…
Aug 10, 2026
Corporate Catalyst
Neutral
Impact 65
RBC Capital Initiates Coverage On Logan energy with Outperform Rating, Announces Price Target of C$1.5
RBC Capital's initiation of coverage on Logan Energy with an 'Outperform' rating and a C$1.5 price target is a positive development for the company. This signals that a major finan…
Jul 22, 2026
Corporate Catalyst
Bearish
Impact 55
RBC Capital Maintains Outperform on Legence, Lowers Price Target to $101
RBC Capital's analyst Sabahat Khan maintained an 'Outperform' rating for Legence (LGN), signaling continued confidence in the company's fundamental performance. However, the price …
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.